EN
HI
Summary
As of 13 Nov, 2026, Eris Lifesciences stock price is ₹1277.8. During the trading session, the stock has moved between an intraday low of ₹1254.20 and an intraday high of ₹1291.00. Over the last 52 weeks, Eris Lifesciences has traded between ₹1069.00 and ₹1740.00.
The stock has recorded a trading volume of 62,030 shares,. Its Average Traded Price (ATP) is ₹1276.24, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹1277.80.
Eris Lifesciences has an upper circuit limit of ₹1530.10 and a lower circuit limit of ₹1020.10. The total value traded stands at ₹7.92 CR, and the delivery percentage for the day is 59.08%.
The stock is currently traded with a market lot size of 1. Eris Lifesciences also offers a dividend yield of 0%.
Eris Lifesciences Share Price Chart
Eris Lifesciences Share Key Metrics
Volume
62030.00
Market Cap
17708.17 CR
LTQ@LTP
2@1277.80
ATP
1276.24
Var Margin
15.55 %
Circuit Range
1020.1-1530.1
Delivery %
59.08 %
Value
7.92 CR
ASM/GSM
No
Market Lot
1
Eris Lifesciences Fundamentals
P/E Ratio
24.99
P/B Ratio
4.27
Div. Yield
0
Sector P/E
41.06
Sector P/B
3.86
Sec. Div. Yield
0.53
Eris Lifesciences Resistance and Support
Pivot 1267.57
Resistance
First Resistance
1289.04
Second Resistance
1302.97
Third Resistance
1324.44
Support
First Support
1253.64
Second Support
1232.17
Third Support
1218.24
Eris Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 12 2026 | 1275.1 | 1277.8 | 0.21% | 1291 | 1254.2 |
| Wed Nov 11 2026 | 1277.3 | 1275.09 | 1.07% | 1281.5 | 1246.09 |
| Mon Nov 09 2026 | 1250 | 1261.59 | 0.71% | 1278.09 | 1250 |
Eris Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-26 | Quarterly Results |
| 2026-07-29 | Quarterly Results |
| 2026-05-20 | Audited Results & Interim Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-24 | Preferential issue of shares |
| 2025-11-12 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-07 | Interim Dividend |
| 2025-02-04 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| 2024-08-02 | Quarterly Results |
Eris Lifesciences News
Eris Lifesciences Ltd - 540596 - Board Meeting Intimation For Consideration And Approval Of The Financial Results For The Period Ended September 30, 2026
Eris Lifesciences board will meet on October 26, 2026, to approve financial results. The agenda covers the performance for the quarter and half-year ended September 30, 2026.
Oct 19 2026 18:30:28
Eris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Period Ended June 30, 2026
Eris Lifesciences board of directors is scheduled to meet on October 26, 2026, to approve the financial results. The results will cover the quarter and half-year ended September 30, 2026.
Oct 19 2026 18:24:46
Eris Lifesciences Management
| Name | Position |
|---|---|
| Milind Talegaonkar | Company Secretary & Compliance Officer |
| Krishnakumar Vaidyanathan | Whole Time Director & COO |
Eris Lifesciences Similar Stocks
Caplin Point Laboratories Ltd.
2386.30
-134.00 (5.32%)
Astrazeneca Pharma India Ltd.
6438.50
-68.50 (1.05%)
Onesource Specialty Pharma Ltd.
1620.00
38.30 (2.42%)
Shilpa Medicare Ltd.
989.65
55.50 (5.94%)
Pfizer Ltd.
3864.40
-28.90 (0.74%)
Dr. Agarwal's Health Care Ltd.
551.25
-2.90 (0.52%)
Cohance Lifesciences Ltd.
471.65
7.55 (1.63%)
Poly Medicure Ltd.
1693.10
19.70 (1.18%)
Natco Pharma Ltd.
808.80
-0.15 (0.02%)
CORONA Remedies Ltd.
2342.20
-25.50 (1.08%)
Eris Lifesciences FAQs
The Buying Price of Eris Lifesciences share is 1277.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Eris Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Eris Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Eris Lifesciences shares is 24.99. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Eris Lifesciences shares is 4.27. Useful to assess the stock's value relative to its book value.
To assess Eris Lifesciences’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Eris Lifesciences is 17708.17 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Eris Lifesciences share price is 1740.00 & 1069.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Eris Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ERIS
